PIA Study Partners
Funding and Research Partners
Our clinical trial, dedicated to investigating the effects of probucol in Alzheimer’s disease, is made possible through the invaluable support of our funding, research and supporting partners.
Funding Partners
Our funding partners including MRFF, the NHMRC, MSWA, The McCusker Charitable Foundation, and the Wen Giving Foundation, provide the essential financial resources that enable us to conduct rigorous and comprehensive research. Their generous contributions ensure that we have access to the latest technologies, top-tier research facilities and the necessary support to carry out our study effectively.
Research Partners
Collaboration with esteemed research institutions including Alzheimer’s Research Australia, the Perron Institute of Neurological and Translational Research, CHIRI, the Wicking Dementia Research and Education Centre of the University of Tasmania, and the Memory Trials Unit of the Central Adelaide Local Health Network, allows us to leverage a wealth of expertise and experience in the field of neurodegenerative diseases. These partnerships facilitate the exchange of knowledge, innovative ideas and advanced methodologies, ensuring our study is grounded in the most current and robust scientific practices.
Supporting Partners
Amana Living, one of Western Australia’s largest not-for-profit aged care providers, is strongly committed to enabling older people to maintain their individuality and lead fulfilling lives. This is why we’re proud to support the Probucol in Alzheimer’s (PIA) Study, connecting the community we serve with research that has the potential to change lives.
Stronger Together
Importance of Partnerships
The synergy created by these collaborations enhances the quality and impact of our research. Our partners’ dedication to scientific excellence and their unwavering support are fundamental to achieving our objectives and ultimately improving the lives of those affected by Alzheimer’s disease.